Postgraduate medicineFeb 4, 2020

Rethinking the use of benzodiazepines for people with long-term pain

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗

Updated Feb 7, 2026

Full Text

Full text is available at the source.

View Full Text ↗

Weekly Psychedelic Science Brief

You found one interesting study. We’ll send the next 7.

Get 7 new psychedelic science papers each week, explained in plain English with direct links to the originals.

what lands in your inbox each week:

📚7 fresh studies
📝plain-language summaries
✅direct links to original studies
🏅top journal indicators
📅weekly delivery
🧘‍♂️always free

Recent issues from the psychedelic science brief

A pill form of ketamine cut dissociation to near-zero vs. nasal spray's 29.6-point spike — but missed its main antidepressant target

2 days ago7 studies

At-home ketamine injections cut depression scores by more than half in 3,870 patients

1 week ago8 studies

Psychedelics disrupt brain signal flow in both humans and mice across LSD, psilocybin, and MDMA

2 weeks ago7 studies

Psilocybin cut depression scores by 35 points in postpartum mothers

3 weeks ago7 studies

Psilocybin's antidepressant effects lasted 12 months in 126 treatment-resistant patients

4 weeks ago7 studies

Buprenorphine extends ketamine's anti-suicide effects for 4 weeks in depression trial

5 weeks ago7 studies

Psilocybin helped 18 out of 20 people stay off cocaine for 6 months

7 weeks ago7 studies

Psilocybin reduces specific brain cells' activity while boosting others

8 weeks ago7 studies

Single dose of psilocybin repairs brain circuits in fetal alcohol syndrome mice

9 weeks ago7 studies

Psilocybin's hallucinations and brain rewiring happen through completely different mechanisms

10 weeks ago7 studies

explore the archive

See more issues from the psychedelic science brief